FDA Panel Strongly Supports Abbott TriClip TEER
CardiacWire
FEBRUARY 14, 2024
Those concerns were echoed online after the FDA panel votes became public, with criticisms largely aligning with the concerns in the panel documents (only QoL, placebo effect) and suggesting that the data doesn’t justify a 13-1 vote.
Let's personalize your content